Chemical Compound
4-Quinazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine; 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline; CH 331; Caprelsa; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-(N-methylpiperidin-4-ylmethoxy)quinazolin-4-amine; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine; Vandetanib; ZD 6474; Zactima
CAS Registry Number
443913-73-3
Primary record
4-Quinazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine; 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline; CH 331; Caprelsa; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-(N-methylpiperidin-4-ylmethoxy)quinazolin-4-amine; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine; Vandetanib; ZD 6474; Zactima
- 库存
- 6,259 克
- 纯度
- 98.4 %
- CAS
- 443913-73-3
化合物标识与属性
- CAS
- 443913-73-3
- PubChem CID
- 3081361
- SMILES
- CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC
- Canonical SMILES
- COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1
名称与同义词
- Vandetanib
- Zactima
- Caprelsa
- 443913-73-3
- ZD6474
- Vandetanib [INN]
- vandetanibum
- vandetanib (zd6474)
- Vandetinib
- Vandetanib-d6
- 2ivu
- ZD-6474
- Caprelsa (TN)
- ZD 6474
- C22H24BrFN4O2
- Vandetanib (Zactima)
- Vandetanib (Standard)
- AC1MIWRU
- GNF-PF-2188
- Zactima, ZD6474
- Kinome_3316
- RefChem:58965
- VANDETANIB [MI]
- Vandetanib (JAN/INN)
- ZD-64
- Microcrystalline cellulose
- VANDETANIB [JAN]
- Vandetanib [USAN:INN]
- UNII-YO460OQ37K
- VANDETANIB [USAN]
- YO460OQ37K
- N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
- DTXSID1046681
- MFCD07772346
- VANDETANIB [VANDF]
- BDBM21
- CHEBI:49960
- CHEMBL24828
- D0G6QF
- AZD-6474
- Vandetanib (ZD6474)?
- SCHEMBL9044
- VANDETANIB [MART.]
- N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine
- NSC-744325
- NSC-760766
- VANDETANIB [WHO-DD]
- Vandetanib, Zactima, ZD6474
- DTXCID9026681
- cc-112
- HSDB 8198
- MLS006011672
- Vandetanib (JAN/USAN/INN)
- Vandetanib (Pan-TK inhibitor)
- AMY599
- GTPL5717
- orb1307862
- QCR-37
- Vandetanib - Bio-X trade mark
- Vandetanib [USAN:INN:BAN:JAN]
- Vandetanib(Zactima),ZD6474/
- SCHEMBL21067679
- SCHEMBL21067681
- SCHEMBL29351698
- SCHEMBL29352879
- VANDETANIB [ORANGE BOOK]
- cid_3081361
- CTK8B9016
- AZD6474
- EX-A422
- L01XE12
- SYN1090
- CH 331
- CH-331
- UHTHHESEBZOYNR-UHFFFAOYSA-N
- BCPP000023
- GLXC-90097
- HMS3244K03
- HMS3244K04
- HMS3244L03
- HMS3654E11
- HMS3672C07
- HMS5087C15
- SMSSF-0113863
- AOB87780
- BCP01925
- ZWB68349
- C22-H24-Br-F-N4-O2
- Tox21_112511
- 443913-73-3 (free base)
- ABP000873
- ANW-61824
- BDBM50595124
- EBC-07806
- HY-10260R
- NCGC00167513-01
- NSC744325
- NSC760766
- NSC800961
- RS0036
- s1046
- ZINC53683345
- AKOS015902350
- Tox21_112511_1
- AC-5251
- ACN-040201
- AN-3469
- CCG-269495
- CID3081361
- CS-0130
- DB05294
- FV28668
- NSC 744325
- NSC 760766
- NSC-800961
- SB16919
- SDCCGSBI-0647658.P002
- CID:3081361
- NCGC00167513-02
- NCGC00167513-03
- NCGC00167513-04
- NCGC00167513-09
- AJ-45811
- AK106976
- AS-11067
- BC224441
- BP-44062
- BV164508
- EN002713
- HY-10260
- SC-23330
- SID:53789193
- SMR002530472
- SY027438
- AB0008635
- AB1008463
- LS-184394
- RT-016214
- ST2407381
- A8555
- CAS-443913-73-3
- F9995-0087
- FT-0656736
- NS00008846
- SW218092-2
- EC-000.2359
- J1.720.281B
- A10963
- A25648
- D06407
- EN300-265835
- N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine
- N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine
- SBI-0647658.0001
- V-9402
- W-5356
- 338992-00-0
- 68541-EP2298768A1
- 68541-EP2308855A1
- AB01273969-01
- AB01273969-02
- AB01273969_04
- 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline
- 913V733
- C452423
- SR-00000000462
- I14-1942
- Q7914515
- SR-00000000462-2
- BRD-K77625799-001-01-0
- BRD-K77625799-001-07-7
- Z2512943095
- 4-Quninazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-
- B2693-344311
- N-(4-bromo-2-fluoro-phenyl)-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazolin-4-amine
- 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-yl)methoxyquinazoline
- 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline
- (4-Bromo-2-fluoro-phenyl)-[6-methoxy-7-(1-methyl-piperidin-4-ylmethoxy)-quinazolin-4-yl]-amine
- 4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE
- (4-bromo-2-fluorophenyl){6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]-4-quinazolinyl}amine
- 4-(4-Bromo-2-fluoroanilino)-6-methoxy- 7-[(1-methylpiperidin-4-yl)methoxy]quinazoline
- 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[ (1-methylpiperidin-4-yl)methoxy]quinazoline
- 4-[(4-Bromo-2-fluorophenyl)amino]-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazoline
- 7-[(1-Methyl-4-piperidinyl)methoxy]-6-methoxy-4-(2-fluoro-4-bromoanilino)quinazoline
- 1174683-49-8
- 4-QUINAZOLINAMINE, N-(4-BROMO-2-FLUOROPHENYL)-6-METHOXY-7-((1-METHYL-4- PIPERIDINYL)METHOXY)-
- 4-Quinazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine; 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline; CH 331; Caprelsa; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-(N-methylpiperidin-4-ylmethoxy)quinazolin-4-amine; N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine; Vandetanib; ZD 6474; Zactima
- N-(2-Fluoro-4-bromophenyl)-6-methoxy-7-[(1-methylpiperidine-4-yl)methoxy]quinazoline-4-amine
- Quinazolin-4-amine, N-(4-bromo-2-fluorophenyl)-6-mthoxy-7-[(1-methyl-4-piperidinyl)methoxy]-
- ZD6